Malignant transformation of struma ovarii into follicular thyroid carcinoma: A case report

卵巢甲状腺肿恶性转化为滤泡性甲状腺癌:病例报告

阅读:1

Abstract

RATIONALE: Struma ovarii is a rare form of mature cystic teratoma, with malignant transformation reported in approximately 5% to 10% of cases. Transformation into follicular thyroid carcinoma (FTC) is extremely uncommon; as a result, no standardized guidelines exist for treatment or prognosis for such cases. PATIENT CONCERNS: A 54-year-old woman with cholelithiasis presented with upper abdominal discomfort. A lower abdominal mass was incidentally detected during evaluation. DIAGNOSES: Transvaginal ultrasonography revealed a 12-cm multilocular cystic tumor in the right ovary. Magnetic resonance imaging and computed tomography findings suggested a mature cystic teratoma with potential for malignant transformation. Exploratory laparotomy was performed, and intraoperative frozen section analysis confirmed malignant transformation. INTERVENTIONS: The patient subsequently underwent total abdominal hysterectomy, bilateral salpingo-oophorectomy, pelvic lymphadenectomy, para-aortic lymph node biopsy, and omentectomy. Histopathological examination revealed tumor cells demonstrating cribriform proliferation, accompanied by eosinophilic structures, extensive necrosis, and venous invasion. These findings supported the diagnosis of FTC arising within struma ovarii. OUTCOMES: Postoperatively, the patient underwent routine follow-up, including serum thyroglobulin tests and imaging studies every 3 months. At 1 year, the patient showed no signs of tumor recurrence and remained in good clinical condition. LESSONS: Malignant transformation of struma ovarii into FTC is an extremely rare condition and necessitates thorough histopathological evaluation for accurate diagnosis. This case highlights the diagnostic and therapeutic challenges associated with such tumors.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。